Weekly Digest - Mar 2024

Weekly Digest - Mar 2024

26 Mar 2024: NextCure and LegoChem Biosciences partner to develop Antibody Drug Conjugates

  • NextCure Inc and LegoChem Biosciences Inc collaborate on developing a B7-H4 antibody-drug conjugate and explore options for two additional targets
  • The B7-H4 ADC will utilize NextCure’s B7-H4 antibody and LegoChem Biosciences’ ConjuAllTM ADC technology
  • Both parties will share development costs and profits equally for commercialized products under the agreement
  • The collaboration aims to advance the B7-H4 ADC to clinical stages, leveraging their respective product development capabilities

For full story click here

Share this